Biochimica et Biophysica Acta-Reviews on Cancer

Article	Citations
Tumour cell-induced platelet aggregation in breast cancer: Scope of metal nanoparticles	371
Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective	253
Modeling bladder cancer in the laboratory: Insights from patient-derived organoids	187
Nutrition and dietary restrictions in cancer prevention	183
miRNAs and androgen deprivation therapy for prostate cancer	154
TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance	153
The interaction of SET and protein phosphatase 2A as target for cancer therapy	126
Advances in epigenetic modifications and cervical cancer research	104
Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique?	104
Reflections on drug resistance to KRAS inhibitors and gene silencing/editing tools for targeting mutant KRAS in cancer treatment	99
ESR1 activating mutations: From structure to clinical application	98
Uveal melanoma modeling in mice and zebrafish	93
Progress and challenges of immunotherapy in triple-negative breast cancer	87
Decoding the role of FOXP3 in esophageal cancer: Underlying mechanisms and therapeutic implications	79
Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies	78
Transcription factors in glioblastoma – Molecular pathogenesis and clinical implications	74
Extracellular vesicles in cancer therapy: Roles, potential application, and challenges	72
Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer	69
In what area of biology has a “new” type of cell death been discovered?	69
Prostate cancer: Molecular aspects, consequences, and opportunities of the multifocal nature	63
Biomarkers in high grade serous ovarian cancer	63
Dual perspective on autophagy in glioma: Detangling the dichotomous mechanisms of signaling pathways for therapeutic insights	61
Advances and prospects of mRNA vaccines in cancer immunotherapy	61
S100A8 and S100A9 in Cancer	58
Insights into the role of connexins and specialized intercellular communication pathways in breast cancer: Mechanisms and applications	56

Long non-coding RNAs: Fundamental regulators and emerging targets of cancer stem cells	53
Fascin-1 in primary liver cancers, perspectives for targeted therapy	52
Targeting lipid metabolism in cancer metastasis	49
Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting	47
Prognostic features of the tumour microenvironment in oesophageal adenocarcinoma	46
Enhancing the anti-tumor response by combining DNA damage repair inhibitors in the treatment of solid tumors	46
Recent insights into RNA m5C methylation modification in hepatocellular carcinoma	46
Multiple impacts of Naa10p on cancer progression: Molecular functions and clinical prospects	45
Multifaceted roles of neutrophils in tumor microenvironment	45
Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy	45
The interplay of obesity, microbiome dynamics, and innovative anti-obesity strategies in the context of endometrial cancer progression and therapeutic approaches	45
Targeting Cdc20 for cancer therapy	45
Long non-coding RNAs: A view to kill ovarian cancer	45
Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and therapeutic potential	45
Interleukin-21 as an adjuvant in cancer immunotherapy: Current advances and future directions	43
Nondiploid cancer cells: Stress, tolerance and therapeutic inspirations	42
Epithelial-Mesenchymal Transition in Cancer: A Focus on Itraconazole, a Hedgehog Inhibitor	42
Antibody-drug conjugates in HER-2 negative breast cancers with poor prognosis	42
Editorial Board	42
Vagus innervation in the gastrointestinal tumor: Current understanding and challenges	41
Matrisomics: Beyond the extracellular matrix for unveiling tumor microenvironment	41
Current advances in comprehensive omics data mining for oncology and cancer research	41
Intestinal multicellular organoids to study colorectal cancer	40
Refinement of safety and efficacy of anti-cancer chemotherapeutics by tailoring their site-specific intracellular bioavailability through transporter modulation	39
The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer	39
Unveiling the potential of gene editing techniques in revolutionizing Cancer treatment: A comprehensive overview	39
Platinum-based systematic therapy in triple-negative breast cancer	39
Ubiquitination/de-ubiquitination: A promising therapeutic target for PTEN reactivation in cancer	38
Antibody-drug conjugates in breast cancer: Marching from HER2-overexpression into HER2-low	38
ASPORIN: A root of the matter in tumors and their host environment	38
In vitro anticancer properties of anthocyanins: A systematic review	37
A role for RIO kinases in the crosshair of cancer research and therapy	36
Focus on mast cells in the tumor microenvironment: Current knowledge and future directions	36
Predictive and prognostic value of PIK3CA mutations in HER2-positive breast cancer treated with tyrosine kinase inhibitors: A systematic review and meta-analysis	36
Implications of viral infection in cancer development	36
Modulation of N-glycosylation in the PD-1: PD-L1 axis as a strategy to enhance cancer immunotherapies	35
Muscle-to-tumor crosstalk: The effect of exercise-induced myokine on cancer progression	35
Cross talk between autophagy and oncogenic signaling pathways and implications for cancer therapy	35
The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights	35
An overview of BAP1 biological functions and current therapeutics	34
Mesenchymal stem cells in glioblastoma therapy and progression: How one cell does it all	34
CD8+ T-cell exhaustion: Impediment to triple-negative breast cancer (TNBC) immunotherapy	34
Advances in clinical immunotherapy for gastric cancer	33
Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment	33
HOXA1, a breast cancer oncogene	32
Overview of splicing variation in ovarian cancer	32
Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma	32
Exosomal non-coding RNAs (ncRNAs) as potential biomarkers in tumor early diagnosis	31
Carbonic anhydrase IX: An atypical target for innovative therapies in cancer	31
Emerging strategies to overcome PARP inhibitors' resistance in ovarian cancer	31

Directing CAR T cells towards the tumor vasculature for the treatment of solid tumors	30
Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma	30
Schwann cells and enteric glial cells: Emerging stars in colorectal cancer	30
Dual role of Snail1 as transcriptional repressor and activator	30
RUNX1 and cancer	29
Colorectal cancer: Metabolic interactions reshape the tumor microenvironment	29
Manipulating macrophage polarization in cancer patients: From nanoparticles to human chimeric antigen receptor macrophages	29
Exploring the gut microbiome: A potential biomarker for cancer diagnosis, prognosis, and therapy	29
Interleukin-1 signaling in solid organ malignancies	28
USP7 - a crucial regulator of cancer hallmarks	28
Data-driven approaches to advance research and clinical care for pediatric cancer	28
A novel approach to reducing disparities in health outcomes by enhancing interpretation of cancer clinical trials for underrepresented patient groups	28
A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitors	28
SNARE proteins: Core engines of membrane fusion in cancer	28
New target DDR1: A “double-edged sword” in solid tumors	28
Strategies for studying immune and non-immune human and canine mammary gland cancer tumour infiltrate	28
Potentially diagnostic and prognostic roles of piRNAs/PIWIs in pancreatic cancer: A review	27
Scientific and clinical relevance of non-cellular tumor microenvironment components in ovarian cancer chemotherapy resistance	27
Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers	27
Keep your eyes peeled for long noncoding RNAs: Explaining their boundless role in cancer metastasis, drug resistance, and clinical application	27
Stress granules dynamics and promising functions in pancreatic cancer	27
New insight into the role of SMAD4 mutation/deficiency in the prognosis and therapeutic resistance of pancreatic ductal adenocarcinomas	27
To kill a cancer: Targeting the immune inhibitory checkpoint molecule, B7-H3	27
Role of F-box proteins in human upper gastrointestinal tumors	26
Keratin 1 as a cell-surface receptor in cancer	26
Augmentation of the EPR effect by mild hyperthermia to improve nanoparticle delivery to the tumor	26
From resistance to resilience: Uncovering chemotherapeutic resistance mechanisms; insights from established models	26
Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment	26
Artificial intelligence and allied subsets in early detection and preclusion of gynecological cancers	26
A special subtype: Revealing the potential intervention and great value of KRAS wildtype pancreatic cancer	25
Epigenetic regulation of cancer-associated fibroblast heterogeneity	25
Consequence of distinctive expression of MUC2 in colorectal cancers: How much is actually bad?	25
Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p53	24
Dual roles of human endogenous retroviruses in cancer progression and antitumor immune response	24
A digital highway for data fluidity and data equity in precision medicine	24
The correlation between gut and intra-tumor microbiota and PDAC: Etiology, diagnostics and therapeutics	24
Improving DCIS diagnosis and predictive outcome by applying artificial intelligence	24
Research progress of mitochondria and cytoskeleton crosstalk in tumour development	24
The clinical significance and correlative signaling pathways of paired box gene 9 in development and carcinogenesis	24
Expression and function of NF-Y subunits in cancer	23
Understanding the role of DNA methylation in colorectal cancer: Mechanisms, detection, and clinical significance	23
Emerging roles of PIWI-interacting RNAs (piRNAs) and PIWI proteins in head and neck cancer and their potential clinical implications	23
Spatiotemporal heterogeneity and clinical challenge of pancreatic neuroendocrine tumors	23
Non-small cell lung cancer: Emerging molecular targeted and immunotherapeutic agents	23
Epidermal growth factor receptor PROTACs as an effective strategy for cancer therapy: A review	23
Epigenetic therapy: Research progress of decitabine in the treatment of solid tumors	22
The interplay between microbiome and host factors in pathogenesis and therapy of head and neck cancer	22
The neoantigens derived from transposable elements – A hidden treasure for cancer immunotherapy	22
Histone deacetylase complexes: Structure, regulation and function	22
Reflecting on the cardiac toxicity in non-small cell lung cancer in the era of immune checkpoint inhibitors therapy combined with thoracic radiotherapy	22
Changing landscape of anti-angiogenic therapy: Novel approaches and clinical perspectives	22
B7-H3 regulates anti-tumor immunity and promotes tumor development in colorectal cancer	22
Role of the intratumoral microbiome in tumor progression and therapeutics implications	22
Role of Yin Yang 1 (YY1) on microenvironment, signaling pathways, and epigenetics in lung cancer	22
Editorial Board	22
Finding the junction between claudins and endometrial carcinoma	22
Clinical considerations of CDK4/6 inhibitors in triple-negative breast cancer	22
Machine Learning in Epigenomics: Insights into Cancer Biology and Medicine	22
Tumoral heterogeneity in neuroblastoma	22
Psychological intervention to treat distress: An emerging frontier in cancer prevention and therapy	21
The signaling pathways regulated by KRAB zinc-finger proteins in cancer	21
Advances in tuft cells, a chemosensory cell in sequential diseases of the pancreas	21
βIII-tubulin overexpression in cancer: Causes, consequences, and potential therapies	21
CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways	21
Clinical and Molecular Attributes and Evaluation of Pancreatic Cystic Neoplasm	21
Tumor microenvironment diversity and plasticity in cancer multidrug resistance	21
Editorial Board	21
Centrosome amplification in cancer and cancer-associated human diseases	21
The role of exosomes in the tumour microenvironment on macrophage polarisation	20
The comparison of pathogenic role and mechanism of Kallistatin and PEDF in tumors	20
Cancer-associated fungi: An emerging powerful player in cancer immunotherapy	20
Advances in glioma models using in vivo electroporation to highjack neurodevelopmental processes	20
Roles of K(H)SRP in modulating gene transcription throughout cancer progression: Insights from cellular studies to clinical perspectives	20
GSDM family and glioma	20
Enhancing immune checkpoint blockade therapy of genitourinary malignancies by co-targeting PMN-MDSCs	20
TERT promoter mutations in gliomas: Molecular roles in tumorigenesis, metastasis, diagnosis, prognosis, therapeutic targeting, and drug resistance	19
Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER+) breast cancer	19
Cyclin-dependent kinases in DNA damage response	19
Protein induced by vitamin K absence or antagonist II: Experience to date and future directions	19
The potential of TRP channels as new prognostic and therapeutic targets against prostate cancer progression	19

Biological function, regulatory mechanism, and clinical application of mannose in cancer	19
Unveiling Cuproptosis: Mechanistic insights, roles, and leading advances in oncology	19
Odors and cancer: Current status and future directions	19
Molecular and immune pathobiology of human angiosarcoma	19
Improving the efficacy of anti-EGFR drugs in GBM: Where we are going?	19
Dietary and serum advanced glycation end-products and clinical outcomes in breast cancer	19
The role of TRIM25 in the occurrence and development of cancers and inflammatory diseases	19
Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy	18
Interstitial fluid pressure as an emerging biomarker in solid tumors	18
RNF43 and ZNRF3: Versatile regulators at the membrane and their role in cancer	18
Precision medicine and phosphoproteomics for the identification of novel targeted therapeutic avenues in sarcomas	18
A review exploring the fusion of oncolytic viruses and cancer immunotherapy: An innovative strategy in the realm of cancer treatment	18
Implication of Toll-Like Receptors in growth and management of health and diseases: Special focus as a promising druggable target to Prostate Cancer	18
Novel therapeutic approaches in GEP-NETs based on genetic and epigenetic alterations	18
Thymic epithelial tumor medical treatment: A narrative review	18
Editorial Board	18
Cancer-associated fibroblasts: Mediators of head and neck tumor microenvironment remodeling	18
Mechanistic regulation of FOXO transcription factors in the nucleus	17
Relevance of tumor microbiome in cancer incidence, prognosis, and its clinical implications in therapeutics	17
Acetyl-CoA regulates lipid metabolism and histone acetylation modification in cancer	17
Bioelectronic medicines: Therapeutic potential and advancements in next-generation cancer therapy	17
Combination therapies with Wnt signaling inhibition: A better choice for prostate cancer treatment	17
The progress of immune checkpoint therapy in primary liver cancer	17
microRNA-205 in prostate cancer: Overview to clinical translation	17
Perioperative immunotherapy for patients with EGFR mutant non-small cell lung cancer: Unexpected potential benefits	17
Unravelling the complexity of lncRNAs in autophagy to improve potential cancer therapy	17
Small extracellular vesicles (exosomes) and their cargo in pancreatic cancer: Key roles in the hallmarks of cancer	17
The dual role of citrate in cancer	16
Editorial Board	16
Editorial Board	16
Advancements in the application of ablative therapy and its combination with immunotherapy in anti-cancer therapy	16
In vitro models: Can they unravel the complexities of cancer cell metastasis?	16
Achievement in active agent structures as a power tools in tumor angiogenesis imaging	16
Fingerprint of the oxido-reductase ERO1: A protein disulfide bond producer and supporter of cancer	16
Glioma and post-translational modifications: A complex relationship	16
E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers	16
Roles of miRNAs in regulating ovarian cancer stemness	16
Intercellular adhesion molecule-1 (ICAM-1): From molecular functions to clinical applications in cancer investigation	15
FGFR signaling and endocrine resistance in breast cancer: Challenges for the clinical development of FGFR inhibitors	15
Advancements in therapeutic peptides: Shaping the future of cancer treatment	15
Bacteria-based cancer therapy: Looking forward	15
Biomechanical properties of laminins and their impact on cancer progression	15
The innate effects of plant secondary metabolites in preclusion of gynecologic cancers: Inflammatory response and therapeutic action	15
Metabolic tricks of cancer cells	15
Targeting transposable elements in cancer: developments and opportunities	15
Editorial Board	15
“Intrinsic disorder-protein modification-LLPS-tumor” regulatory axis: From regulatory mechanisms to precision medicine	14
Recent thymic emigrants as the bridge between thymoma and autoimmune diseases	14
Gene regulation by the tumor suppressor p53 – The omics era	14
Efficacy and safety of trastuzumab with or without a tyrosine kinase inhibitor for HER2-positive breast cancer: A systematic review and meta-analysis	14
Modulation of Ca2+ signaling by antiapoptotic Bcl-2 versus Bcl-xL: From molecular mechanisms to relevance for cancer cell survival	14
Decoding β-catenin associated protein-protein interactions: Emerging cancer therapeutic opportunities	14
The association between the neuroendocrine system and the tumor immune microenvironment: Emerging directions for cancer immunotherapy	14
The role of autophagy in pancreatic cancer progression	14
Drug resistance in colorectal cancer: An epigenetic overview	13
Metastasis prevention: How to catch metastatic seeds	13
Glioblastoma preclinical models: Strengths and weaknesses	13
Spartin: At the crossroad between ubiquitination and metabolism in cancer	13
DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer	13
Retraction notice to “Coagulation and inflammation in cancer: Limitations and prospects for treatment” [Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877 (2022) 188727]	13
Drivers of cancer metastasis – Arise early and remain present	13
Advances and challenges in therapeutic resistant biomarkers of neuroblastoma: A comprehensive review	13
Ferroptosis and its interaction with tumor immune microenvironment in liver cancer	13
Clinical applications of deep learning in breast MRI	13
Targeting the heat shock response induced by modulated electro-hyperthermia (mEHT) in cancer	13
Membrane drug transporters in cancer: From chemoresistance mechanism to therapeutic strategies	13
Recent advances in understanding the molecular role of phosphoinositide-specific phospholipase C gamma 1 as an emerging onco-driver and novel therapeutic target in human carcinogenesis	13
The key role of matrix stiffness in colorectal cancer immunotherapy: mechanisms and therapeutic strategies	13
Cullin-RING Ligase 4 in Cancer: Structure, Functions, and Mechanisms	13
New insights into exosome mediated tumor-immune escape: Clinical perspectives and therapeutic strategies	12
The potential of methioninase for cancer treatment	12
MOMP: A critical event in cell death regulation and anticancer treatment	12
Exploration of tumor penetrating peptide iRGD as a potential strategy to enhance tumor penetration of cancer nanotherapeutics	12
Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunity	12
The role of the NDRG1 in the pathogenesis and treatment of breast cancer	12
The role of 5-HT metabolism in cancer	12
New advances in the therapeutic strategy of head and neck squamous cell carcinoma: A review of latest therapies and cutting-edge research	12
Structure, function, signaling pathways and clinical therapeutics: The translational potential of STAT3 as a target for cancer therapy	12
Advancements in immunotherapy for gastric cancer: Unveiling the potential of immune checkpoint inhibitors and emerging strategies	12
Targeting nanoparticles to malignant tumors	12
Mechanisms of cancer cachexia and targeted therapeutic strategies	11
Vitamin K: New insights related to senescence and cancer metastasis	11
Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model	11
Tumor-associated neutrophils and neutrophil-targeted cancer therapies	11
Targeting Bcl-2 for cancer therapy	11
Corrigendum to “Recent thymic emigrants as the bridge between thymoma and autoimmune diseases” [Biochim Biophys Acta Rev Cancer. 2022;1877(3):188730.]	11
The potential roles of p53 signaling reactivation in pancreatic cancer therapy	11
Activity and resistance to KRASG12C inhibitors in non-small cell lung cancer and colorectal cancer	11
Current and future directions of USP7 interactome in cancer study	11
Role of exosomes in lung cancer: A comprehensive insight from immunomodulation to theragnostic applications	11
Editorial Board	11
Functional impact of non-coding RNAs in high-grade breast carcinoma: Moving from resistance to clinical applications: A comprehensive review	11
Leveraging preclinical models of metastatic breast cancer	11
Find the path of least resistance: Adaptive therapy to delay treatment failure and improve outcomes	11
Phase separation in DNA damage response: New insights into cancer development and therapy	11